Name | FEN1-IN-4 |
Synonyms | FEN1-IN-4 FEN1 Inhibitor C2 1-(Cyclopropylmethyl)-3-hydroxyquinazoline-2,4(1H,3H)-dione 2,4(1H,3H)-Quinazolinedione, 1-(cyclopropylmethyl)-3-hydroxy- |
CAS | 1995893-58-7 |
Molecular Formula | C12H12N2O3 |
Molar Mass | 232.24 |
Storage Condition | Inert atmosphere,Store in freezer, under -20°C |
In vitro study | FEN1 inhibition selectively impairs proliferation of colon cancer cells deficient in Cdc4 and Mre11a , both frequently mutated in colorectal cancers. FEN1 has also emerged as a potential chemosensitizing target due to its role in LP-BER since it is critical for repair of Methyl methanesulfonate-induced alkylation damage, and its knockdown or inhibition increases sensitivity to Temozolomide in glioblastoma and colorectal cancer cell lines. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 4.306 ml | 21.529 ml | 43.059 ml |
5 mM | 0.861 ml | 4.306 ml | 8.612 ml |
10 mM | 0.431 ml | 2.153 ml | 4.306 ml |
5 mM | 0.086 ml | 0.431 ml | 0.861 ml |
bioactivity | FEN1-IN-4 (Compound 2) is a human skin flap endonuclease 1 (hFEN1) inhibitor. |
Target | hFEN1 |